*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Design, Development And Evaluation Of Antidiabetc Matrix Tablets Using Natural And Synthetic Polymers

Author: HIMABINDU PEDDAPALLI, MADHURIKA SIRIGADI , MD FAHEEMUDDIN, RAMKOTESWARA RAO AMARA, ANANDA KUMAR CHETTUPALLI
Abstract: This research was conducted to create anti-diabetic tablets from chemicals that have been compressed using a mechanized direct compression process. The tablets were chemically tested and their release in-vitro experiments were also performed. Different batches of hydrophilic polymer content and Karaya Gum formed tablets with uniform hardness (3-4mm) and thickness (2-3mm). The friability (0.29-0.51%), weight variance (1.18-2.54%), and Substance quality (95.40-98.86%) of multiple tablets was identified inside the limits prescribed. The swelling degree was associated with polymer standard irrespective of whether it was a diluent or polymer. The release profile showed that increasing the concentration of the copolymer had retarded the release of Gliclazide irrespective of the kind of polymer used. Both drug release from all matrix tablets is caused by polymer swelling and relaxation with ratio lies 0.45 to 0.89. Therefore, the FTIR study showed no chemical reactions between medication and polymers used. According to the samples, the sample was found to be hard and the overall substance concentration was over 98 percent at the end of the study. Among the formulations in which F2 HPMCK100M hydrochloride tablets have the best continuous release of glipizide. Using triggered epilepsy rats to evaluate the time course of the drug.
Keyword: Matrix tablets; Sustained release; Gliclazide;Direct compression; In- vitro release.
DOI: https://doi.org/10.31838/ijpr/2021.13.01.599
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free